Skip to main
LITS
LITS logo

LITS Earnings Dates & Reports

LITS Most Recent Earnings

Report DateSep 18, 2024
Period EndingQ4 2024
Est. EPS-$1.43
Actual EPS-$1.12
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

LITS Earnings per Share (EPS) History

Signup for full access
Browse free

LITS Latest Earnings

The value each LITS share was expected to gain vs. the value each share gained.

LITS reported its most recent earnings on Sep 18, 2024 for Q4 2024, posting earnings per share (EPS) of -$1.12. This exceeded analysts' expectations of -$1.43 by 21.68%, marking a Beat.

For comparison, MEI Pharma Inc reported EPS of -$1.51 in the same quarter last year.

The company is expected to announce its next earnings report on 11/11/2025, with analysts projecting an EPS of $0.

LITS Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2026Nov 11, 2025
Next earnings call Nov. 11, 2025
Q4 2025Sep 26, 2025
-$0.40
Q3 2025May 13, 2025
-$0.39
Q2 2025Feb 12, 2025
-$0.40
Q1 2025Nov 12, 2024
-$1.20
View all

LITS Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the MEI Pharma Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Sep 26, 2025
May 13, 2025
Feb 12, 2025
Nov 12, 2024

LITS Earnings FAQs

LITS last reported earnings on Sep 18, 2024 for Q4 2024, posting an EPS of -$1.12, which Beat the estimate of -$1.43 by 21.68%.

For Q4 2024, LITS reported an EPS of -$1.12, exceeding analysts' estimate of -$1.43 by 21.68%.

For Q4 2024, LITS Beat expectations with an actual EPS of -$1.12 vs. an estimated EPS of -$1.43.

Following the last earnings report on Sep 18, 2024, LITS's stock price moved — from — to —.

The next LITS earnings call is scheduled for Nov. 11, 2025, where executives will discuss financial results and outlook.

MEI Pharma Inc (LITS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.